REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/26/2025
Back to search
Official data from USPTO
SMARTPHLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SMARTPHLEX
ST13
US500000079250945Class
9, 35, 40, 42, 44
Filing
79250945
Registration
6060922
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
05/27/2025
Trademark type
Word
Nice classes
9, 35, 40, 42, 44
Filing date
07/02/2018
Registration date
05/26/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2020
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
CHOE, JULIE
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PharmaLex GmbH
Representatives
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Technical classification
Nice Classes
Class 9Class 35Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Software for supporting product development processes and regulatory compliance; software for automation of routine processes and report generation; artificial intelligence software for supporting decision making processes; computer programs for data processing; downloadable computer software applications for supporting product development processes and regulatory compliance; unified communications software for supporting decision making processes; assistive software for supporting product development processes and regulatory compliance; all the foregoing in the fields of medical devicesconsumer healthcareanimal healthcarepharmaceuticals and biopharmaceuticals
Class 35
Advertising servicesbusiness management for otherscompany administration in the nature of business administration services; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy services in the field of retailing services and wholesaling services related to medicines; provision of outsourcing services in the field of business management for companies engaged in the field of medicine developmentauthorizationproductionsalesafety and monitoring; assistance and consultancy in the field of business management of companies engaged in medicine and medical device authorization and lifecycle maintenanceautomation of content compilation and document dossier developmentautomation for creation of documents for achieving medical marketing authorization and marketing approval; regulatory submission managementassisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documentsreports and files required by regulatory authorities via automation of content compilation and document dossier developmentautomation for creation of documents for achieving medical marketing authorization and marketing approval
Class 40
Assistance and consultancy in the context of medicine productionmanufacturing process consulting
Class 42
Scientific and technological services and research and design relating theretoscientific research and laboratory research in the field of pharmaceuticals; industrial analysis and research serviceslaboratory research services relating to pharmaceuticals and pharmaceutical research services; research and development of new products for others in the field of pharmaceuticals; provision of scientific surveys in the field of pharmaceuticals in the nature of scientific research; development of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; scientific research; scientific research and analysis in the field of pharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology consultancy services provided to the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticalspharmaceutical product evaluation; new product design servicesanalysis and evaluation of product design; product development consultationanalysis and evaluation of new product development; quality control testing for othersproduct testing; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for others to determine conformity with certification standards; developmentupdating and maintenance of software and database systems; development of software for data and multimedia content conversion from and to different protocols; Providing temporary use of on-linenon-downloadable software for publishing and printing written materials for improving gains in efficiency with client operations; providing temporary use of on-line non-downloadable software for the management of information; providing temporary use of on-line non-downloadable software for the transmission of information; providing temporary use of on-line non-downloadable software for the transmission of data; providing temporary use of on-line non-downloadable software for the management of data; software as a service (SAAS) services featuring software for the management and transmission of information and data; rental of software for data processing; all the foregoing in the fields of medical devicesconsumer healthcareanimal healthcarepharmaceuticals and biopharmaceuticals
Class 44
Medical and veterinary medical services; pharmacy advice in the nature of pharmaceutical advice; providing information relating to medicine; providing information relating to the preparation and dispensing of medications; advisory services relating to pharmaceuticalspharmaceutical advice
Publications
History of USPTO decisions and trademark events.
42 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/17/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/24/2020
FIMP
FINAL DISPOSITION PROCESSED
09/24/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/26/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2020
PUBO
PUBLISHED FOR OPPOSITION
03/10/2020
GPNX
NOTIFICATION PROCESSED BY IB
03/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/19/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/28/2020
GNFR
FINAL REFUSAL E-MAILED
01/28/2020
CNFR
FINAL REFUSAL WRITTEN
01/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2019
GNRT
NON-FINAL ACTION E-MAILED
09/04/2019
CNRT
NON-FINAL ACTION WRITTEN
09/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2019
ALIE
ASSIGNED TO LIE
08/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2019
RFNT
REFUSAL PROCESSED BY IB
03/16/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/22/2019
RFRR
REFUSAL PROCESSED BY MPU
02/21/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/13/2019
CNRT
NON-FINAL ACTION WRITTEN
02/12/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2019
DOCK
ASSIGNED TO EXAMINER
02/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/31/2019
Continuous trademark protection
Get notified about every new filing that threatens SMARTPHLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.